Response of Darier Disease Following Treatment With Baricitinib

JAMA Dermatol. 2022 Jun 1;158(6):699-701. doi: 10.1001/jamadermatol.2022.1021.
No abstract available

MeSH terms

  • Azetidines* / adverse effects
  • Darier Disease* / diagnosis
  • Darier Disease* / drug therapy
  • Humans
  • Purines / therapeutic use
  • Pyrazoles / adverse effects
  • Sulfonamides

Substances

  • Azetidines
  • Purines
  • Pyrazoles
  • Sulfonamides
  • baricitinib